MedPath

Cardiorespiratory fitness in newly diagnosed patients with Relapsing Remitting Multiple Sclerosis compared to matched healthy controls: already lagging behind from the start?

Recruiting
Conditions
Multiple Sclerosis (MS)
10012303
Registration Number
NL-OMON48103
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
32
Inclusion Criteria

MS patients
In order to be eligible to participate in this study, the MS patients must meet all of the following criteria:
- definite diagnosis of Relapsing Remitting MS according to the most recent international diagnostic criteria;
- diagnosis within 12 months prior to inclusion date;
- disease severity: EDSS score of maximal 2 with normal pyramidal and cerebellar functions (i.e. Functional Systems Score for pyramidal functions = 0 and Functional Systems Score for cerebellar functions = 0).
- age at definite diagnosis between 18-65 years.

Healthy Siblings/Controls (controls)
In order to be eligible to participate in this study, the healthy controls must meet the following criteria:
- healthy sibling of participant with MS, and matching with respect to sex, age (± 5 years), level of physical activity in the past year;
- healthy persons, matching to MS participants with respect to sex, age (± 5 years), and level of physical activity in the past year.
- age between 18-65 years

Exclusion Criteria

- Physician-confirmed diagnosis of (other) neurological disorders or systemic or malignant neoplastic diseases.
- Serious comorbidities precluding Cardiopulmonary Exercise test (CPET) or Lung function examination.
- Use of heart rate regulating medication (e.g. Beta-blockers).
- Use of medication for lung diseases.
- Being pregnant, or receiving medical help/fertility treatment to become pregnant.
- Body Mass Index of 30 or higher.
- Sports and exercise activities in the past year of > 10 hours/week.
- Does not speak Dutch.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Maximal exercise capacity, lung function, and mitochondrial function of<br /><br>muscles.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Blood parameters: Haemoglobin concentration, hematocrit, C-reactive protein<br /><br>(CRP).</p><br>
© Copyright 2025. All Rights Reserved by MedPath